To determine GR activity, a 200 L assay consisted of 0.15 mM GSSG, 0.15 mM NADPH, and 20 L of the desalted floret extract, in 0.1 M NaH 2 PO 4 buffer (pH 7.5) containing 20 mM EDTA
GH directly stimulates lipolysis, the process of breaking stored fat into free fatty acids that can be burned for energy
Composition & Format Active: FOXO4 peptide (FOXO4-DRI analog) Strength: 10 mg FOXO4 per vial Format: White lyophilized peptide powder Standard kit: 10 vials per kit for wholesale orders Origin: China-based factory, export-ready documentation available on request Key Features for Wholesale Buyers High-purity (99%) FOXO4 peptide for senolytic and anti-aging research projects Factory-direct supply with flexible OEM/ODM and labeling options Consistent quality across batches, suitable for long-term study designs Competitive wholesale pricing for bulk kits and repeat orders Packaging & Ordering Standard packaging: 10 mg/vial, 10 vials per kit in sealed plastic trays Each tray is protected with bubble wrap and export carton for secure international shipping Typical dispatch updates provided within 3 business days after payment confirmation For bulk pricing, OEM labels, or combined peptide orders, please contact our sales team directly Storage & Handling Store FOXO4 peptide kits in a sealed container at 28 C , away from light and moisture For long-term storage, keep vials tightly closed and minimize freezethaw cycles Use reconstituted solutions promptly under appropriate laboratory conditions Related Products Follistatin-344 muscle & tissue support peptide kit LL-37 immune & inflammation support peptide kit Blend TB-500 5 mg + BPC-157 5 mg + GHK-Cu 50 mg advanced healing peptide kit Compliance Notes THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY
Drug prescribing and pharmacy fulfillment are excluded
69.95 KLOW 80mg KLOW is a research compound supplied in a precisely measured 80mg unit, intended for use in controlled laboratory and analytical settings
An in vitro study by Lieberman et al, demonstrated that GLP-1 RA inhibits chemokine-related migration of human CD4+ lymphocytes (47)
